Nanowear is the leading developer of patented, textile-based nanosensor technology with applications in the cardiac, neurological, diabetic and sports medicine / performance diagnostics monitoring markets. The company’s proprietary technology enables wireless, real-time electrophysiological monitoring that provides medical professionals with accurate, continuous diagnostics data through a cost effective and non-invasive wearable deployment. Nanowear’s core focus on innovation and next-gen technologies will continue to propel the company towards exploring unique and groundbreaking applications for its nanosensors. Headquartered in New York City, the company’s research and development center is located in University Park, Pennsylvania.

Nanowear is the leading developer of patented, textile-based nanosensor technology with applications in the cardiac, neurological, diabetic and sports medicine / performance diagnostics monitoring markets. The company’s proprietary technology enables wireless, real-time electrophysiological monitoring that provides medical professionals with accurate, continuous diagnostics data through a cost effective and non-invasive wearable deployment. Nanowear’s core focus on innovation and next-gen technologies will continue to propel the company towards exploring unique and groundbreaking applications for its nanosensors. Headquartered in New York City, the company’s research and development center is located in University Park, Pennsylvania.

#1 doctor recommended personal EKG. The most clinically validated six-lead personal EKG. It’s a smart device you can trust.

AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. AliveCor is pioneering the creation of FDA-cleared 'machine learning' techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared Kardia Mobile is the most clinically validated mobile ECG solution on the market and is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. This simple-to-use mobile device and app-based service provides instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an ECG. Kardia Pro is the first AI-enabled platform for doctors to monitor patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia that leads to a five times greater risk of stroke. AliveCor was recognized by Fast Company as one of 2017's most innovative companies in health (#3). AliveCor is a privately-held company headquartered in Mountain View, California.